Studies related to Depression and Uridine

Open-Label Uridine for Treatment of Depressed Adolescents with Bipolar Disorder
Effect Decrease
Trial Design cohort
Trial Length 16months
Number of Subjects 7
Sex mixed
Notes for this study:
In an open-label trial with 1g Uridine daily for 6 weeks, there was significant improvement on depressive symptoms of bipolar disorder in adolescents. Treatment was well tolerated, and manic symptoms were not assessed but did not appear to be drastically exacerbated.